Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Post by Starsearcher80on Jul 05, 2022 8:47am
227 Views
Post# 34801270

SELL RECOMMENDATIONS EVERYWHERE

SELL RECOMMENDATIONS EVERYWHEREGlobe says Canopy debt plan leaves analysts unmoved 04:27 The Globe and Mail reports in its Tuesday edition that analysts have kept their sell ratings on Canopy Growth's shares despite its move last week to offload nearly one-fifth of its debt to address investor concerns. The Globe's Irene Galea writes that Canopy had made a deal with several of its debtholders to exchange $255.4-million worth of debt for shares and about $3-million in cash as part of its efforts to become profitable by 2024. Since the announcement Canaccord Genuity, CIBC Capital Markets and Piper Sandler & Co. have all reiterated their sell ratings. Canaccord's Matthew Bottomley says swapping the debt for equity increases Canopy's total outstanding share count by 56 to 78 million shares, up to about 20 per cent. He says this is bad news for current investors who worry that with more debt on the books, more share dilution may be on the horizon. He adds that while the reduction of debt is positive, it is not enough for the investment firm to upgrade its sell recommendation to hold or even buy. Canopy's story is representative of the bleak financial situation of all Canada's large cannabis producers, whose profitability is suffering because of high competition for products and low brand recognition.
<< Previous
Bullboard Posts
Next >>